Syneos Health
SYNH
SYNH was delisted on the 27th of September, 2023.
313 hedge funds and large institutions have $7.2B invested in Syneos Health in 2020 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 143 increasing their positions, 80 reducing their positions, and 40 closing their positions.
79% more repeat investments, than reductions
Existing positions increased: 143 | Existing positions reduced: 80
43% more first-time investments, than exits
New positions opened: 57 | Existing positions closed: 40
18% more capital inflows, than outflows
Capital inflows: $916M | Capital outflows: $775M
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
4% more funds holding
Funds holding: 300 → 313 (+13)
1.38% more ownership
Funds ownership: 100.23% → 101.61% (+1.4%)
20% less call options, than puts
Call options by funds: $4.22M | Put options by funds: $5.28M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$74.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$72.3M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$51.3M |
| 4 |
HealthCor Management
New York
|
+$49.5M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$43.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Advent International
Boston,
Massachusetts
|
-$201M |
| 2 |
Thomas H. Lee (THL) Partners
Boston,
Massachusetts
|
-$173M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$104M |
| 4 |
Goldman Sachs
New York
|
-$28.4M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$23.8M |
SYNH Hedge Fund Activity: Q4 2020 in Review
313 of the 5,680 institutional investors tracked by Wall St. Rank reported a position in Syneos Health (SYNH) for Q4 2020, worth a combined $7.2B — up 29% from $5.57B a quarter earlier.
Buyers outnumbered sellers: 57 funds opened new SYNH positions and 40 closed out — a net gain of 17 holders — while 143 added to existing stakes and 80 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $74.8M. The largest seller was Advent International, cutting an estimated $201M.
- 313 institutional investors held Syneos Health (SYNH) as of Q4 2020, up from 300 in Q3 2020.
- Funds reported $7.2B of Syneos Health stock for Q4 2020, up 29% quarter-over-quarter.
- 57 funds opened new Syneos Health positions in Q4 2020 and 40 closed out, a net change of +17 holders.
- The largest Syneos Health buyer in Q4 2020 was Wellington Management Group, an estimated $74.8M added.
- The largest Syneos Health seller in Q4 2020 was Advent International, an estimated $201M sold.
Based on aggregated 13F filings for Q4 2020.